De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Elevance Health Balans Gezondheid
Financiële gezondheid criteriumcontroles 4/6
Elevance Health heeft een totaal eigen vermogen van $42.3B en een totale schuld van $30.4B, wat de schuld-eigenvermogensverhouding op 71.8% brengt. De totale activa en totale passiva bedragen respectievelijk $113.0B en $70.7B. De EBIT Elevance Health is $10.5B waardoor de rentedekking 9.9 is. Het heeft contanten en kortetermijnbeleggingen van $36.0B.
Belangrijke informatie
71.8%
Verhouding schuld/eigen vermogen
US$30.39b
Schuld
| Rente dekkingsratio | 9.9x |
| Contant | US$35.99b |
| Aandelen | US$42.30b |
| Totaal verplichtingen | US$70.69b |
| Totaal activa | US$112.99b |
Recente financiële gezondheidsupdates
Is Elevance Health (NYSE:ELV) Using Too Much Debt?
Apr 16
Is Elevance Health (NYSE:ELV) A Risky Investment?
Jan 02These 4 Measures Indicate That Elevance Health (NYSE:ELV) Is Using Debt Safely
Oct 04Here's Why Elevance Health (NYSE:ELV) Can Manage Its Debt Responsibly
Jul 05We Think Elevance Health (NYSE:ELV) Can Stay On Top Of Its Debt
Apr 04Elevance Health (NYSE:ELV) Seems To Use Debt Rather Sparingly
Nov 28Recent updates
Investors Continue Waiting On Sidelines For Elevance Health, Inc. (NYSE:ELV)
Sep 11Elevance Health: Strong Earnings Growth Supports Strong Dividend Growth
Sep 06There's Been No Shortage Of Growth Recently For Elevance Health's (NYSE:ELV) Returns On Capital
Aug 29Here's Why We Think Elevance Health (NYSE:ELV) Is Well Worth Watching
Aug 02Elevance Health: Healthcare Services Segment Is Gaining Traction
Jul 31Elevance Health: Buy A Dividend Growth Machine
Jul 18Elevance Health: Favorable Trends Are Emerging (Rating Upgrade)
Jun 28Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?
Jun 11Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher
May 27We Think Shareholders Will Probably Be Generous With Elevance Health, Inc.'s (NYSE:ELV) CEO Compensation
May 09Elevance Health (NYSE:ELV) Has Announced A Dividend Of $1.63
Apr 25Elevance Health: It's Not Too Late To Buy Their Dividend Growth
Apr 23Is Elevance Health (NYSE:ELV) Using Too Much Debt?
Apr 16Elevance Health: Not Doing Enough In 2024 To Justify Premium Price
Apr 11Elevance Health, Inc.'s (NYSE:ELV) Earnings Haven't Escaped The Attention Of Investors
Apr 01Elevance: A Healthy Dose Of Dividend Growth
Mar 21Elevance Heath: Financial Growth And Technical Strength Indicate A Buy
Mar 07Elevance Health (NYSE:ELV) Will Pay A Larger Dividend Than Last Year At $1.63
Feb 19Elevance Health: Time To Buy This Incredible Dividend Growth Stock
Jan 26Slowing Rates Of Return At Elevance Health (NYSE:ELV) Leave Little Room For Excitement
Jan 19Is Elevance Health (NYSE:ELV) A Risky Investment?
Jan 02Elevance Health, Inc.'s (NYSE:ELV) Shares Not Telling The Full Story
Dec 18A Look At Elevance's Margin Dynamics
Nov 23Is It Time To Consider Buying Elevance Health, Inc. (NYSE:ELV)?
Nov 16Elevance Health: A High Conviction Defensive Blue Chip Buy
Oct 19These 4 Measures Indicate That Elevance Health (NYSE:ELV) Is Using Debt Safely
Oct 04Elevance: Pave The Way For The Next UnitedHealth
Sep 21Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital
Sep 18Here's The Price I Would Buy Elevance Health Stock
Sep 13If EPS Growth Is Important To You, Elevance Health (NYSE:ELV) Presents An Opportunity
Aug 18Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?
Aug 04Narrowing Down High-Quality Dividend Growth: Elevance Health Is Elemental
Jul 24Elevance Health: Beaten Down Share Price Offers Solid Potential
Jul 10Here's Why Elevance Health (NYSE:ELV) Can Manage Its Debt Responsibly
Jul 05Elevance Health: A Critical Update (Rating Downgrade)
Jun 05Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher
Jun 04Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?
May 05We Think Elevance Health (NYSE:ELV) Can Stay On Top Of Its Debt
Apr 04Elevance Health's (NYSE:ELV) Dividend Will Be Increased To $1.48
Feb 17Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital
Feb 13Elevance Health: Attractive On Its Expansion Catalysts
Feb 09Elevance Health (NYSE:ELV) Has Announced That It Will Be Increasing Its Dividend To $1.48
Jan 28Elevance Health acquiring Blue Cross and Blue Shield of Louisiana
Jan 23Elevance Health Offers Great Value
Jan 17At US$483, Is Elevance Health Inc. (NYSE:ELV) Worth Looking At Closely?
Jan 17Elevance Health: Strong And Steady EPS Growth Ahead, High Relative Strength Name
Jan 02Elevance Health (NYSE:ELV) Seems To Use Debt Rather Sparingly
Nov 28Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( $62.3B ) ELV } overtreffen de korte termijn passiva ( $41.8B ).
Langlopende schulden: De kortetermijnactiva ELV ( $62.3B ) overtreffen de langetermijnschulden ( $28.9B ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: ELV heeft meer geld in kas dan de totale schuld.
Schuld verminderen: De schuld/eigen vermogen-ratio van ELV is de afgelopen 5 jaar gestegen van 64.5% naar 71.8%.
Schuldendekking: De schuld van ELV wordt niet goed gedekt door de operationele kasstroom ( 6.8% ).
Rentedekking: De rentebetalingen op de schuld van ELV worden goed gedekt door EBIT ( 9.9 x dekking).